128 filings
Page 2 of 7
8-K
qpwe3rl q5dvnd
11 Oct 23
Other Events
8:01am
8-K
dvz8jevev29jn3rp
3 Oct 23
Other Events
9:28am
424B3
7c9jw
3 Oct 23
Prospectus supplement
9:27am
8-K
30l1 43tp5p5d
27 Sep 23
Disrupting Convention in Women’s Health Through Continuous Innovation September 2023 Corporate Presentation 1
8:19am
8-K
1yrpim 5pxgt0n
6 Sep 23
Submission of Matters to a Vote of Security Holders
5:00pm
8-K
7piyg810f
10 Aug 23
Femasys Inc. Announces Financial Results for the Second Quarter Ended Second Quarter 2023 Financial Results
8:05am
8-K
t3ozdibn8row7m
3 Aug 23
Femasys Initiates Enrollment in Pivotal Trial of its Permanent Birth Control Candidate FemBloc
9:04am
8-K
y34e8wmzeopd0
27 Jul 23
Femasys Announces Notice of Allowance for New U.S. Patent Application Covering Use of FemBloc for Female Permanent Birth Control
9:04am
EFFECT
qwxc94
17 Jul 23
Notice of effectiveness
12:15am
424B3
svr8u
14 Jul 23
Prospectus supplement
4:16pm
CORRESP
mq3yuq1guke
12 Jul 23
Correspondence with SEC
12:00am
CORRESP
ht1cqhimx9 n9d6
7 Jul 23
Correspondence with SEC
12:00am
UPLOAD
mojdzgernl uh
5 Jul 23
Letter from SEC
12:00am
8-K
urlpo70
26 Jun 23
Disrupting Convention in Women’s Health Through Continuous Innovation June 2023 Corporate Presentation 1
8:05am